ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 83 filers reported holding ALLOVIR INC in Q4 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $59,554 | -4.2% | 82,336 | 0.0% | 0.01% | +20.0% |
| Q1 2024 | $62,155 | +11.0% | 82,336 | 0.0% | 0.01% | +11.1% |
| Q4 2023 | $55,972 | -68.4% | 82,336 | 0.0% | 0.01% | -83.3% |
| Q3 2023 | $177,022 | -36.8% | 82,336 | 0.0% | 0.05% | +10.2% |
| Q2 2023 | $279,942 | -13.7% | 82,336 | 0.0% | 0.05% | -26.9% |
| Q1 2023 | $324,404 | -23.2% | 82,336 | 0.0% | 0.07% | -26.4% |
| Q4 2022 | $422,384 | -35.0% | 82,336 | 0.0% | 0.09% | -40.1% |
| Q3 2022 | $650,000 | +102.5% | 82,336 | 0.0% | 0.15% | +76.7% |
| Q2 2022 | $321,000 | -42.3% | 82,336 | 0.0% | 0.09% | -38.6% |
| Q1 2022 | $556,000 | -47.8% | 82,336 | 0.0% | 0.14% | -32.4% |
| Q4 2021 | $1,065,000 | -48.4% | 82,336 | 0.0% | 0.21% | -36.1% |
| Q3 2021 | $2,063,000 | +27.0% | 82,336 | 0.0% | 0.32% | +61.2% |
| Q2 2021 | $1,625,000 | -15.7% | 82,336 | 0.0% | 0.20% | -43.4% |
| Q1 2021 | $1,927,000 | -39.1% | 82,336 | 0.0% | 0.36% | +11.6% |
| Q4 2020 | $3,165,000 | +26.4% | 82,336 | -9.6% | 0.32% | -54.4% |
| Q3 2020 | $2,504,000 | – | 91,057 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,323,371 | $15,683,000 | 0.66% |
| GMT CAPITAL CORP | 1,138,070 | $7,682,000 | 0.48% |
| RA Capital Management | 1,440,525 | $9,724,000 | 0.21% |
| Redmile Group, LLC | 823,371 | $5,558,000 | 0.17% |
| Samsara BioCapital, LLC | 82,336 | $556,000 | 0.14% |
| Woodline Partners LP | 1,087,093 | $7,338,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 93,166 | $629,000 | 0.08% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,532 | $7,719,000 | 0.04% |
| Virtus ETF Advisers LLC | 10,463 | $71,000 | 0.03% |
| PDT Partners, LLC | 30,198 | $204,000 | 0.02% |